Clinical trial
A Prospective, Randomized, Controlled, Multicenter Trial to Evaluate the Safety and Efficacy of Deep Transcranial Magnetic Stimulation (Deep TMS) With a New Stimulation Protocol in Subjects With Major Depression Disorder (MDD)
NCT06357832 is registered in ClinicalTrials.gov with Brainsway as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective, Randomized, Controlled, Multicenter Trial to Evaluate the Safety and Efficacy of Deep Transcranial Magnetic Stimulation (Deep TMS) With a New Stimulation Protocol in Subjects With Major Depression Disorder (MDD)
- Lead sponsor
- Brainsway
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- April 29, 2024
- Completion date
- March 5, 2026
- Enrollment
- 104 (actual)
- Sites
- 9
Conditions
As the registry lists them; a condition with its own page is linked.